Antibody Therapy (Record no. 29008)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02194nam a22002777a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241002094359.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | 20241002094359.0 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241002095900.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241002b |||||||| |||| 00| 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2017954301 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-68037-8 |
| International Standard Book Number | 978-3-319-68038-5 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.994 061 IMB |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Paul Imbach |
| 245 ## - TITLE STATEMENT | |
| Title | Antibody Therapy |
| Remainder of title | Substitution – Immunomodulation – Monoclonal Immunotherapy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Medical Faculty of the University of Basel Basel Switzerland | |
| Name of publisher, distributor, etc. | Springer International Publishing AG, part of Springer Nature | |
| Date of publication, distribution, etc. | 2018. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 361 Pages |
| Extent | Includes References |
| 490 ## - SERIES STATEMENT | |
| Series statement | https://doi.org/10.1007/978-3-319-68038-5 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP). Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Hematology, Immunology, Internal medicine, Medical / Clinical Medicine, Medical / Hematology, Medical / Immunology, Medical / Internal Medicine, Biological response modifiers, Immunoglobulins -- Therapeutic use, Medicine, Oncology. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href=" https://doi.org/10.1007/978-3-319-68038-5 "> https://doi.org/10.1007/978-3-319-68038-5 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/02/2024 | 616.994 061 IMB | 20241002094359.0 | 10/02/2024 | 10/02/2024 | E-BOOKS |